Particularly, it is showcased that intratumoural injection of synthetic cyclic dinucleotides (CDN) could elicit rapidly the IFN-β expression by immune cells in tumours and generate anti-tumour specific CD8+ T cells to inhibit tumours development [93]. The gene discussed is CD8A; the disease is neoplasm.